Biomarin Pharmaceutical (BMRN) Return on Sales [ROS] (2009 - 2026)
Biomarin Pharmaceutical's Return on Sales [ROS] was 11.21% in Q2 2026, down 22.34 percentage points from 33.55% a year earlier and down 5.71 percentage points from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biomarin Pharmaceutical's Return on Sales [ROS] was 4.38% through Jun 30, 2026, down 20.95 percentage points year-over-year; for FY2025, it was 12.71%, down 4.25 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of +15.05 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was 16.97% in FY2024 (+9.29 pp), 7.68% in FY2023 (unchanged), 7.68% in FY2022 (+12.14 pp) and -4.46% in FY2021 (-2.12 pp).
- Quarterly Return on Sales [ROS] has moved between -14.65% (Q4 2021) and 33.55% (Q2 2025) over five years.
- Compared with a year earlier, Return on Sales [ROS] has declined for four straight quarters, with an average year-over-year change of -2.88 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2022 (a gain of 21.28 percentage points); the worst was Q4 2025 (a drop of 26.70 percentage points).
- Per Business Quant data, BMRN's Return on Sales [ROS] in the three quarters before Q2 2026 was 16.92% (Q1 2026), -5.10% (Q4 2025) and -6.02% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn | 11.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.21% |
| Mar 31, 2026 | 16.92% |
| Dec 31, 2025 | -5.10% |
| Sep 30, 2025 | -6.02% |
| Jun 30, 2025 | 33.55% |
| Mar 31, 2025 | 30.05% |
| Dec 31, 2024 | 21.60% |
| Sep 30, 2024 | 15.27% |
| Jun 30, 2024 | 16.92% |
| Mar 31, 2024 | 13.63% |
| Dec 31, 2023 | 4.22% |
| Sep 30, 2023 | 5.25% |
| Jun 30, 2023 | 11.01% |
| Mar 31, 2023 | 10.46% |
| Dec 31, 2022 | -2.43% |
| Sep 30, 2022 | -0.48% |
| Jun 30, 2022 | 7.33% |
| Mar 31, 2022 | 26.44% |
| Dec 31, 2021 | -14.65% |
| Sep 30, 2021 | -13.02% |
API Access
Biomarin Pharmaceutical Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();